Evidence map›Paper›PMID 41234581›Full record

ArticleTranslational lung cancer research2025

Characterization of

Ying Ding, Gang Chen, Xiao He, Yuqian Shi, Chunhong He, Jiani C Yin, Zhihong Zhang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational lung cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. AccurateInternational journal of molecular sciences · 2025
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ying DingDepartment of Pathology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0000-0001-5581-3058
Gang ChenDepartment of Pathology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Xiao HeDepartment of Pathology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.
Yuqian ShiGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China.ORCID https://orcid.org/0000-0003-1863-5840
Chunhong HeGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China.ORCID https://orcid.org/0000-0003-0997-0583
Jiani C YinGeneseeq Research Institute, Nanjing Geneseeq Technology Inc., Nanjing, China.ORCID https://orcid.org/0000-0002-9523-1930
Zhihong ZhangDepartment of Pathology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.ORCID https://orcid.org/0000-0002-5779-9365

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Rearranged during transfection ( Methods: This retrospective study included 40 NSCLC patients with Results: Patients were predominantly female (67.5%) and never-smokers (87.5%), with a median age of 53 years. All patients underwent FISH, while 39 cases underwent RNA-seq, with one excluded due to RNA quality control failure. The most common fusions were Conclusions: Our findings underscore the complexity of

Indexed as

DNA sequencing (DNA-seq)fluorescence in situ hybridization (FISH)Non-small cell lung cancer (NSCLC)rearranged during transfection fusion (RET fusion)targeted RNA sequencing

Identifiers

PMID41234581
PMCPMC12605241

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.